Propranolol on Post Stroke Immune Status and Infection

NCT05375240 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Stroke
Cerebrovascular Disorders
Ischemic Stroke
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Cardiovascular Diseases
Propranolol
Beta Blocker
Molecular Mechanisms of Pharmacological Action
Immunologic Factors
Physiological Effects of Drugs

Interventions

DRUG: Propranolol
DRUG: Ceftriaxone

Sponsor

Tianjin Medical University General Hospital